Alerts will be sent to your verified email
Verify Email
LUPIN
Insufficient data
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Lupin Limited is a global pharmaceutical company known for its wide range of branded and generic formulations, biotechnology products, and APIs. It specializes in various therapy segments and is a leader in Anti-TB and Cephalosporins segments.
Lupin major competitors are Zydus Lifesciences, Mankind Pharma, Dr. Reddy's Lab, Abbott India, Alkem Laboratories, Aurobindo Pharma, Glenmark Pharma.
Market Cap of Lupin is ₹86,717 Crs.
While the median market cap of its peers are ₹68,151 Crs.
Lupin seems to be less financially stable compared to its competitors.
Altman Z score of Lupin is 6.95 and is ranked 5 out of its 8 competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | May Jun | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Sep Dec | Dec | ||
| Investor Presentation | May Aug | Mar Jun Sep Dec | Mar Jun Sep Dec | Jan Feb Mar May Jun Aug Sep Dec | Jan Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Dec | Mar | ||||
| Conference Call | Mar Jun | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Jun Sep Dec | Dec | ||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
